Additionally, most anti-cancer treatments can induce apoptosis in cancer cells [63] but CSCs in prostate and breast cancer exhibit enhanced expression of a potent anti-apoptotic molecule, B-cell lymphoma 2 (Bcl-2) [64, 65], thereby counteracting drug-induced apoptosis. The gene discussed is BCL2; the disease is cancer.